Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02065648 · ClinicalTrials.gov registry record
Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet
A clinical trial of Vascular Disease, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT02065648: Completed study of Vascular Disease, sponsored by Cedars-Sinai Medical Center.
NCT02065648 is a study of Vascular Disease that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 20 participants, below the 802-participant average among 9 other Vascular Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02065648, a study of Vascular Disease, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare non-contrast abdominal MR Angiogram (MRA) syngo NATIVE sequence performed on a 3T Verio Siemens magnet to a standard contrast-enhanced MRA performed as part of routine clinical care in patients with normal renal function to determine if the non-contrast NATIVE sequence is a viable alternative to contrast enhanced MRA in patients with renal insufficiency. There are no interventions--this is an observational study.
Primary Outcome
Compare non-contrast enhanced MRA images with contrast-enhanced MRA images.
Conditions Studied
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-03 |
What the finished NCT02065648 record still lists
NCT02065648 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 802-participant average among 9 other Vascular Disease trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Vascular Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02065648 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02065648 about?
NCT02065648 is a clinical study titled "Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet". The purpose of the study is to compare non-contrast abdominal MR Angiogram (MRA) syngo NATIVE sequence performed on a 3T Verio Siemens magnet to a standard contrast-enhanced MRA performed as part of routine clinical care in patients with normal renal function to determine if the non-contrast NATIVE ...
What is the current status of trial NCT02065648?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-05. Estimated completion is 2015-03.
What conditions does trial NCT02065648 study?
This clinical trial studies the following conditions: Vascular Disease.
Who is sponsoring clinical trial NCT02065648?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02065648 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02065648's enrollment target sits among peer trials
20 9th of 9 higher than 1 of 9 other Vascular Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Studies of Neuregulin/ERBB Signaling in Human Heart
RECRUITING
-
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
RECRUITING
-
Use of Autologous Concentrated Bone Marrow Aspirate in Preventing Wound Complications in Below Knee Amputation (BKA)
COMPLETED · Phase 1
-
Study of Abnormal Blood Clotting in Children With Stroke
COMPLETED
-
Healthy Heart Amputation Rehabilitation Treatment (H.A.R.T)
COMPLETED · Phase 2
-
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia